Definium Therapeutics Inc (MNMD) Live Share Price, Invest From India

Definium Therapeutics Inc Stock Performance

as on January 15, 2026 at 7:59 am IST

Day's Low
Day's High
$14.31
Day's Price Range
$15.16
$15.00
4.60%
Downside
1.07%
Upside
52 Week's Low
52 Week's High
$6.35
52-Week Price Range
$15.29
$15.00
57.70%
Downside
1.93%
Upside

Definium Therapeutics Inc share price movements today

Previous Close: $14.87
Open: $14.86
Volume: 2.2M
Day's Low - High: $14.31 - $15.16
52 Week Low - High: $6.35 - $15.29

Definium Therapeutics Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Definium Therapeutics Inc Stock Fundamentals & Key Indicators

Check Definium Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Definium Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Definium Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Definium Therapeutics Inc	BUY	$-	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$39.2B	112.69%	73.55	12.55%
Vertex Pharmaceuticals Inc	BUY	$115.0B	104.13%	26.89	35.51%
BeiGene, Ltd.	NA	$31.6B	NA	68.92	8.94%
Regeneron Pharmaceuticals Inc	BUY	$74.7B	36.84%	17.39	29.65%

Analyst Recommendation on Definium Therapeutics Inc Stock

Based on 14 analysts

BUY

92.86%

Buy

7.14%

Hold

0.00%

Sell

Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Definium Therapeutics Inc. Average target price of $28.67

Definium Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Definium Therapeutics Inc.

What analysts predicted

47.68%UPSIDE

Target Price

$28.67

Current Price

$15

Analyzed by

14 Analysts

Target

$28.67

Definium Therapeutics Inc target price $28.67, a slight upside of 47.68% compared to current price of $15. According to 14 analysts rating.

Definium Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	-	4	-	-	-	-	-	-	-
Gross Profit	0	0	4	0	-	-	-	-	-	-
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-29	-17	-23	-54	-5	-13	-34	-23	-42	-67
Net Profit Margin	0.00%	0.00%	-493.26%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Definium Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-
Gross Profit	-	-2	-3	-3	0
Operating Income	-	-	-	-	-
EBITDA	-	-	-	-	-
Interest Expense	-	-	-	-	-
Depreciation	-	-	-	-	-
Income Before Tax	-	-	-	-	-
Income Tax Expense	-	-	-	-	-
Net Income	-34	-93	-56	-95	-108
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%

Global Institutional Holdings in Definium Therapeutics Inc

Funds	Holdings
Blackstone Inc	4.71%
Morgan Stanley - Brokerage Accounts	0.9%
Woodline Partners LP	0.66%
Rosalind Advisors, Inc.	0.55%
BlackRock Inc	7.63%

See all

Insights on Definium Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, MNMD has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 7 days, MNMD stock has moved up by 8.5%
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, MNMD has outperformed top 5 stocks with highest market-cap in its industry

About Definium Therapeutics Inc

Mind Medicine (MindMed) Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. The Company is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, its lead product candidates. Its lead product candidate, MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that the Company is developing for the treatment of generalized anxiety disorder and major depressive disorder. Its second lead product candidate, MM402, also referred to as R(-)-MDMA, is its proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

Organisation	Definium Therapeutics Inc
E-voting on shares	Click here to vote

FAQs

What is Definium Therapeutics Inc share price today?

Definium Therapeutics Inc share price today is $15 as on January 15, 2026 at 2:29 am IST at the close of the market. Definium Therapeutics Inc share today touched a day high of $15.16 and a low of $14.31.

What is the 52 week high and 52 week low for Definium Therapeutics Inc share?

Definium Therapeutics Inc share touched a 52 week high of $15.29 on January 8, 2026 and a 52 week low of $6.35 on June 23, 2025. Definium Therapeutics Inc stock price today i.e. January 15, 2026 at 2:29 am IST is closed at $15,which is 1.90% down from its 52 week high and 136.41% up from its 52 week low.

How to invest in Definium Therapeutics Inc Stock (MNMD) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Definium Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Definium Therapeutics Inc Shares that will get you 0.1000 shares as per Definium Therapeutics Inc share price of $15 per share as on January 15, 2026 at 2:29 am IST.

What is the minimum amount required to buy Definium Therapeutics Inc Stock (MNMD) from India?

Indian investors can start investing in Definium Therapeutics Inc (MNMD) shares with as little as ₹96.5325 or $1 (as of May 20, 2026 at 10:51 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹965.33 in Definium Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on May 20, 2026 at 10:51 am IST). Based on Definium Therapeutics Inc share’s latest price of $15 as on January 15, 2026 at 2:29 am IST, you will get 0.6667 shares of Definium Therapeutics Inc. Learn more about fractional shares .